JPMorgan views the recent pullback in shares of TASER as a buying opportunity and calls yesterday's press release regarding deployments of AXON and EVIDENCE.com across 11 law enforcement agencies a positive. The firm says its talks with management suggest TASER is on track for 10% CAGR for the device business for the next several years. It keeps an Overweight rating on the stock.